drugset / Trial / NCT01566877

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers

NCT01566877 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and tolerability of healthy male and female subjects with intravenous (IV) infusions of AVI 7288 compared to matched placebo in and to evaluate the pharmacokinetics (PK).

Timeline

Start
2013-05
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator AVI-7288 Antisense oligonucleotide 1 mg/kg Intravenous
Comparator AVI-7288 Antisense oligonucleotide 4 mg/kg Intravenous
Comparator AVI-7288 Antisense oligonucleotide 8 mg/kg Intravenous
Comparator AVI-7288 Antisense oligonucleotide 12 mg/kg Intravenous